All funds

DNB Fund - Women's Health N NOK Accumulating

Equity fund

No data to display ...

1 year

Globe

USA

Largest region

High

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years

Details

  • DNB Fund Women’s Health er et globalt, tematisk aksjefond som investerer i selskaper som utvikler produkter og tjenester rettet mot kvinners helsebehov gjennom hele livsløpet. Investeringsuniverset omfatter selskaper på tvers av sektorer, fra legemidler og medisinsk teknologi til diagnostikk og konsumentrettet helse
    Read more

Investment horizon

  • DNB Fund - Women's Health N NOK Accumulating is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • NAV/Price
  • Margin rate
  • Start date
  • ISIN
    LU3443186898

Risk

  • High (5 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Annual cost

  • Ongoing costs
    Includes management fees of 0,85 %
  • Platform fee
  • Kickback fee
  • Annual running costs

Other costs

  • Performance-based fee
  • Transaction costs

  • Costs for any currency exchanges are not included.

Allocation

  • No data

Portfolio

Shows the fund's largest investments.

  • argenx SE
    5.6%
  • AstraZeneca PLC
    5.5%
  • Eli Lilly and Co
    4.8%
  • Roche Holding AG Ordinary Shares new
    4.4%
  • TG Therapeutics Inc
    4.3%